| 李佳佳,张小鹏,张俊青,等.2021年安徽省合肥市甲状腺癌流行特征及2013—2021年变化趋势分析[J].中国肿瘤,2025,34(3):188-194. |
| 2021年安徽省合肥市甲状腺癌流行特征及2013—2021年变化趋势分析 |
| Incidence and Mortality of Thyroid Cancer in Hefei City， Anhui Province in 2021 and the Trend from 2013 to 2021 |
| 投稿时间：2024-08-07 |
| DOI：10.11735/j.issn.1004-0242.2025.03.A004 |
|
 |
| 中文关键词: 甲状腺癌 发病率 死亡率 趋势 安徽 |
| 英文关键词:thyroid cancer incidence mortality trend Anhui |
| 基金项目: |
|
| 摘要点击次数: 183 |
| 全文下载次数: 37 |
| 中文摘要: |
| 摘 要： ［目的］ 分析2021年安徽省合肥市甲状腺癌流行特征及2013—2021年变化趋势。［方法］ 利用合肥市肿瘤登记处数据，计算2021年合肥市甲状腺癌粗发病（死亡）率及中标发病（死亡）率、世标发病（死亡）率等指标。采用Joinpoint软件计算2013—2021年粗发病（死亡）率和中标发病（死亡）率的平均年度变化百分比（average annual percentage change，AAPC），分析甲状腺癌的流行趋势。［结果］ 2021年合肥市甲状腺癌粗发病率为47.54/10万，中标发病率为42.30/10万，世标发病率为35.85/10万。甲状腺癌粗死亡率为0.70/10万，中标死亡率为0.38/10万，世标死亡率为0.40/10万。甲状腺癌发病率在50～54岁年龄组达到高峰，死亡率则在85岁及以上组达到高峰。女性发病率和死亡率均高于男性，城市发病率和死亡率均高于农村地区。2013—2021年合肥市甲状腺癌中标发病率和中标死亡率均呈上升趋势（AAPC分别为38.23%、9.68%，P均＜0.05）。［结论］ 2013—2021年合肥市甲状腺癌中标发病率和中标死亡率均呈上升趋势，需加强防控，减少危险因素暴露，同时需规范诊疗，避免过度诊断。 |
| 英文摘要: |
| Abstract：［Purpose］ To analyze the incidence and mortality of thyroid cancer in Hefei of Anhui Province in 2021 and the trend from 2013 to 2021. ［Methods］ Using the data of Hefei Cancer Registry， the crude incidence/mortality rate， age-standardized incidence/mortality rate by Chinese standard population (ASIRC/ASMRC) and world standard population (ASIRW/ASMRW) were calculated in 2021. The average annual percentage change (AAPC) of the crude incidence/mortality rate and age-standardized incidence/mortality rate were calculated using Joinpoint software to analyze trends from 2013 to 2021. ［Results］ In 2021， the crude incidence rate of thyroid cancer in Hefei was 47.54/105， the ASIRC was 42.30/105， the ASIRW was 35.85/105. The crude mortality rate of thyroid cancer was 0.70/105， the ASMRC was 0.38/105， the ASMRW was 0.40/105. The incidence rate of thyroid cancer reached its peak in the 50~54 age group and the mortality rate reached its peak in the group over 85 years old. The incidence rate and mortality rate of women were higher than those of men， and the incidence and mortality rates in urban areas were higher than those in rural areas. The incidence and mortality of thyroid cancer showed a upward trend from 2013 to 2021 in Hefei City (AAPC were 38.23% and 9.68%， both P<0.05). ［Conclusion］ The ASIRC/ASMRC of thyroid cancer showed a upward trend from 2013 to 2021 in Hefei City. It is necessary to strengthen prevention and control to reduce the exposure of risk factors. At the same time， diagnosis and treatment should be standardized to avoid over diagnosis. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|